Physician

Jahan Q. Zeb, MD

According to 2025 Medicare claims, Jahan Zeb, MD (NPI: 1699710996) practices cardiology in the Joplin, MO-KS market, with the plurality of this provider's patient population coming from Jasper, MO. This provider's primary affiliated billing organization is MERCY CLINIC JOPLIN LLC (NPI: 1215264817; TIN: 611604897) and primary practice location at 64804-4524. Zeb is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616) and CHSPSC ACO 8, LLC (ACO ID: A3715), participating under the MSSP model.

Zeb's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,843 traditional Medicare patients, billed 5,497 HCPCS/CPT codes, and received $200,017 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 12,670 prescription claims across 1,585 beneficiaries totaling $1,841,229 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 11 claims. Open Payments data shows 21 records totaling $439. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $108,096 to $1,841,229. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,502 to $22,279.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,441	2,844	$161,112
2016	2,471	5,617	$223,985
2017	3,167	7,280	$262,038
2018	3,325	7,772	$299,031
2019	3,718	8,900	$341,492
2020	3,094	6,993	$297,353
2021	3,066	7,053	$332,344
2022	3,254	6,984	$281,186
2023	3,079	6,340	$242,870
2024	2,843	5,497	$200,017

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	355	2,598	$108,096
2016	438	3,238	$165,178
2017	623	4,623	$313,418
2018	955	6,194	$610,883
2019	1,079	6,555	$728,519
2020	1,086	6,836	$704,399
2021	1,379	9,902	$1,257,165
2022	1,474	12,078	$1,765,054
2023	1,527	12,285	$1,927,514
2024	1,585	12,670	$1,841,229

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$2,128
2016	N/R	26	$1,533
2017	N/R	30	$1,303
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	22	$1,111
2021	N/R	11	$22,279
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	238	269	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	581	700	$57
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	753	777	$46
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	146	147	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,654	1,999	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	847	42,941	$834,536
Entresto	Sacubitril/Valsartan	499	25,005	$555,071
Xarelto	Rivaroxaban	248	12,344	$228,703
Repatha Sureclick	Evolocumab	37	1,994	$39,659
Jardiance	Empagliflozin	32	1,380	$27,894

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$439	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jahan Q. Zeb, MD?

Tedicare shows public-source Medicare data for Jahan Q. Zeb, MD (NPI 1699710996), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jahan Q. Zeb, MD have ACO affiliation data?

Jahan Q. Zeb, MD is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616) and CHSPSC ACO 8, LLC (MSSP, ACO ID A3715).

What billing organization is linked to Jahan Q. Zeb, MD?

Jahan Q. Zeb, MD is linked to MERCY CLINIC JOPLIN LLC (billing NPI 1215264817) in the available physician profile data.

Does Jahan Q. Zeb, MD have Open Payments data?

Jahan Q. Zeb, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.